Biocryst Pharmaceuticals Stock Performance

BioCryst Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  697.00  in BioCryst Pharmaceuticals on November 21, 2025 and sell it today you would earn a total of  29.00  from holding BioCryst Pharmaceuticals or generate 4.16% return on investment over 90 days. BioCryst Pharmaceuticals is currently generating 0.1087% in daily expected returns and assumes 2.8455% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than BioCryst, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days BioCryst Pharmaceuticals is expected to generate 1.14 times less return on investment than the market. In addition to that, the company is 3.81 times more volatile than its market benchmark. It trades about 0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 per unit of volatility.

BioCryst Pharmaceuticals Target Price Odds to finish over Current Price

Given the investment horizon of 90 days BioCryst Pharmaceuticals has a beta of 0.7 suggesting as returns on the market go up, BioCryst Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BioCryst Pharmaceuticals will be expected to be much smaller as well. Additionally BioCryst Pharmaceuticals has an alpha of 0.0186, implying that it can generate a 0.0186 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for BioCryst Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioCryst Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 4.45 7.27 10.09 Details

Intrinsic Valuation Low Real High 6.53 10.84 13.66 Details

Naive Forecast Low Next High 4.57 7.40 10.22 Details

12 Analysts Consensus Low Target High 19.72 21.67 24.05 Details

BioCryst Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BioCryst Pharmaceuticals is not an exception. The market had few large corrections towards the BioCryst Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioCryst Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioCryst Pharmaceuticals within the framework of very fundamental risk indicators.

BioCryst Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioCryst Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioCryst Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

BioCryst Pharmaceuticals Price Density Drivers

BioCryst Pharmaceuticals Fundamentals Growth

When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.